IDH1 and IDH2 mutations are frequent events in central chondrosarcoma and central and periosteal chondromas but not in other mesenchymal tumours-Reference-Cited by-同舟云学术

IDH1 and IDH2 mutations are frequent events in central chondrosarcoma and central and periosteal chondromas but not in other mesenchymal tumours

Published:2011-05-19 Issue:3 Volume:224 Page:334-343
ISSN:0022-3417
Container-title:The Journal of Pathology
language:en
Short-container-title:J. Pathol.

Author:

Amary M Fernanda,Bacsi Krisztian,Maggiani Francesca,Damato Stephen,Halai Dina,Berisha Fitim,Pollock Robin,O'Donnell Paul,Grigoriadis Anita,Diss Tim,Eskandarpour Malihe,Presneau Nadège,Hogendoorn Pancras CW,Futreal Andrew,Tirabosco Roberto,Flanagan Adrienne M

Funder

Skeletal Cancer Action Trust (SCAT) UK

Publisher

Wiley

Subject

Pathology and Forensic Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/path.2913/fullpdf

Reference53 articles.

1. IDH1 and IDH2 mutations in gliomas;Yan;N Engl J Med,2009

2. IDH1 and IDH2 mutations are prognostic but not predictive for outcome in anaplastic oligodendroglial tumors: a report of the European Organization for Research and Treatment of Cancer Brain Tumor Group;van den Bent;Clin Cancer Res,2010

3. Acquired mutations in the genes encoding IDH1 and IDH2 both are recurrent aberrations in acute myeloid leukemia (AML): prevalence and prognostic value;Abbas;Blood,2010